Activating and inhibitory FcgammaRs in autoimmune disorders.
about
Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysisThe SCHOOL of nature: I. Transmembrane signaling.Fcgamma receptors modulate pulmonary inflammation by activating innate immune cells in murine hypersensitivity pneumonitis.Mechanisms of Autoantibody-Induced Pathology.A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis.FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.Induced expression of FcγRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-γhigh subset.Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?The chicken leukocyte receptor complex encodes a primordial, activating, high-affinity IgY Fc receptor.FcγRI mediates serum amyloid P inhibition of fibrocyte differentiationGenetics of SLE: functional relevance for monocytes/macrophages in diseaseUse of mouse models to study the mechanisms and consequences of RBC clearance.The isotype repertoire of antibodies against novel UH-RA peptides in rheumatoid arthritis.The role of Fc receptors in HIV prevention and therapy.Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury.Autoimmunity-driven enzymatic remodeling of the dermal-epidermal junction in bullous pemphigoid and dermatitis herpetiformis.Targeting B cells and autoantibodies in the therapy of autoimmune diseases.Chemically synthesized molecules with the targeting and effector functions of antibodies.Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model.No association of primary Sjögren's syndrome with Fcγ receptor gene variants.Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins.Intravenous immunoglobulin up-regulates the expression of the inhibitory FcgammaIIB receptor on B cells.
P2860
Q28471918-907433B8-F718-4D4C-B559-3820F8F92C2BQ33351190-70F190AD-1040-4F76-A9F1-AB57AAA70BFDQ33722008-BF96A3DF-1AFF-453B-B620-6C149D0720DEQ33740580-4C5E2CEB-02DF-4F9E-9992-D81D56A1BA85Q34005103-EC37EB39-44BB-4AC3-A69E-EF07B972457BQ34117524-48485C59-D296-4928-93EF-EC1DF94AECC7Q35104018-671185D5-C006-4E5D-93A6-5C988EFA9964Q35434205-BF261384-C9A8-43D5-AEC8-89D9E86594E4Q35880314-3D3BEEF2-3623-4E04-970F-8EE7CBE36195Q36232242-329129F6-D270-442E-9214-702A8C6976C7Q36438876-0585F8A6-D186-40E3-80FD-ADCBB9613429Q36632113-7BB4ACAF-3F69-4EFB-840C-F542CEBA19A5Q36976399-166438CB-B03B-4873-B382-A94090CEEC78Q37113972-16E046F2-96E1-48FB-8FF7-110F0F007300Q37436638-921F3E96-4270-4F1F-8AE5-D0D44BEBAD8FQ37931875-76A765B7-5C15-4D61-BDA6-9F67B8D24C00Q38207937-BF819281-FC4A-4C7E-9615-7EFE580A7CABQ38928032-84C5D3B1-3B94-45D7-BD33-D0110B9DD442Q40213039-24931374-99DE-485D-9BD9-8FA095C85D33Q46093255-4BC6FB1A-0F7F-41CA-8F2B-B82AB865137AQ47132349-326F0EB5-A412-41D0-9FD2-A3E7DD08DEA2Q47674860-9B58FE04-FFBE-48B2-BF22-F52E490A5726
P2860
Activating and inhibitory FcgammaRs in autoimmune disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Activating and inhibitory FcgammaRs in autoimmune disorders.
@ast
Activating and inhibitory FcgammaRs in autoimmune disorders.
@en
type
label
Activating and inhibitory FcgammaRs in autoimmune disorders.
@ast
Activating and inhibitory FcgammaRs in autoimmune disorders.
@en
prefLabel
Activating and inhibitory FcgammaRs in autoimmune disorders.
@ast
Activating and inhibitory FcgammaRs in autoimmune disorders.
@en
P2860
P1476
Activating and inhibitory FcgammaRs in autoimmune disorders
@en
P2093
Falk Nimmerjahn
P2860
P2888
P304
P356
10.1007/S00281-006-0052-1
P577
2006-10-01T00:00:00Z